TrialLancet (London, England)2017

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial.

Paul E Sax et al.PubMed ↗Publisher ↗

No numbers read from the abstract.